Q2

Consolidated net sales increased to SEK 10.0 (7.0) million.

The operating loss improved to SEK 7.7 (9.9) million.

The group cut its loss for Q2 to SEK 7.9 (9.7) million.

Earnings per share for the period amounted to SEK -0.02 (-0.03).

Cash and cash equivalents were SEK 47.0 (76.2) million at the end of the quarter.

FIRST HALF-YEAR

Consolidated net sales increased to SEK 14.6 (14.2) million.

The operating loss improved to SEK 16.6 (20.8) million.

The group cuts its loss for the period to SEK 16.7 (20.4) million.

Earnings per share for the period amounted to SEK -0.05 (-0.06).

Cash and cash equivalents were SEK 47.0 (76.2) million at the end of the quarter. 

SIGNIFICANT EVENTS IN Q2

Precise BioMatch Mobile was integrated into eight cell phones under the group's partnership with Fingerprint Cards.

A licensing agreement was signed with Chinese sensor manufacturer Silead.

Precise Biometrics was awarded the 2015 Frost & Sullivan Award for Global Customer Value Leadership in Fingerprint Biometrics for Mobile Devices.

Smart card reader Tactivo was approved for use with Swedish healthcare system Pascal.

Major order for Tactivo from leading NHS trust in the UK.

Follow-up order for Tactivo from the Defense Logistics Agency (DLA), an agency of the U.S. Department of Defense.

SIGNIFICANT EVENTS AFTER THE END OF THE QUARTER

A licensing agreement was signed with Taiwanese sensor manufacturer ELAN Microelectronics.

Precise BioMatch Mobile was integrated into five more cell phones under the group's partnership with Fingerprint Cards.

Follow-up order for Tactivo from NHS trust in the UK.

Another follow-up order for Tactivo from the Defense Logistics Agency (DLA).